Skip to main content
. 2020 Aug 2;56(4):106129. doi: 10.1016/j.ijantimicag.2020.106129

Fig. 2.

Figure 2

a Kaplan-Meier survival curve for patients with an unfavorable outcome in function of treatment according to lymphocyte count ≥1000/mm3 (Log-Rank, P = 0.04).

b Kaplan-Meier survival curve for patients with an unfavorable outcome in function of treatment according to CRP ≥100 mg/L (Log-Rank, P = 0.009).